Michelle A Petri

Michelle A Petri

UNVERIFIED PROFILE

Are you Michelle A Petri?   Register this Author

Register author
Michelle A Petri

Michelle A Petri

Publications by authors named "Michelle A Petri"

Are you Michelle A Petri?   Register this Author

58Publications

2097Reads

23Profile Views

Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE.

Lupus Sci Med 2019 30;6(1):e000318. Epub 2019 Mar 30.

Research and Development, Exagen, Vista, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/lupus-2019-000318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519690PMC
March 2019

Associates and predictors of pleurisy or pericarditis in SLE.

Lupus Sci Med 2017 23;4(1):e000221. Epub 2017 Oct 23.

Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/lupus-2017-000221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663266PMC
October 2017

Hydroxychloroquine-Induced Erythema Multiforme.

J Clin Rheumatol 2017 Mar;23(2):127-128

Department of Medicine, Saint Agnes Hospital, Baltimore, MD Beaumont Hospital, Dublin, Ireland Hopkins Lupus Center, Department of Medicine, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321779PMC
March 2017

Monocyte enhancers are highly altered in systemic lupus erythematosus.

Epigenomics 2015 7;7(6):921-35. Epub 2015 Oct 7.

Division of Allergy & Immunology, The Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/epi.15.47DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864065PMC
September 2016

H3K4 tri-methylation breadth at transcription start sites impacts the transcriptome of systemic lupus erythematosus.

Clin Epigenetics 2016 2;8:14. Epub 2016 Feb 2.

Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-016-0179-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736279PMC
April 2016

Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.

J Rheumatol 2014 Feb 1;41(2):300-9. Epub 2013 Nov 1.

From the State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Cedars-Sinai Medical Center/David Geffen School of Medicine at the University of California at Los Angeles; Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; North Shore-Long Island Jewish Health System, Lake Success, New York; Los Angeles County + University of Southern California Medical Center and University of Southern California Keck School of Medicine, Los Angeles, California; University of Alabama at Birmingham, Alabama; MedStar Washington Hospital Center, Washington, DC; Oklahoma Center for Arthritis Therapy and Research, Tulsa, Oklahoma; University of Michigan, Ann Arbor, Michigan; Human Genome Sciences Inc., Rockville; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.121368
Publisher Site
http://dx.doi.org/10.3899/jrheum.121368DOI Listing
February 2014

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response.

Ann Rheum Dis 2012 Aug 15;71(8):1343-9. Epub 2012 Feb 15.

Unit for Clinical Therapy Research, Inflammatory Diseases, The Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2011-200937DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396451PMC
August 2012

Differences between male and female systemic lupus erythematosus in a multiethnic population.

J Rheumatol 2012 Apr 1;39(4):759-69. Epub 2012 Mar 1.

Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 7500, Baltimore, MD 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.111061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605704PMC
April 2012

Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis.

Expert Rev Clin Immunol 2012 Mar;8(3):269-84

Johns Hopkins University Bloomberg School of Public Health, Department of Environmental Health Sciences, 615 N. Wolfe Street, Baltimore, MD 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eci.12.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318944PMC
March 2012

The TNFalpha locus is altered in monocytes from patients with systemic lupus erythematosus.

Clin Immunol 2007 Apr 5;123(1):74-81. Epub 2007 Feb 5.

Allergy Immunology, The Children's Hospital of Philadelphia, 34th Street and Civic Ctr. Boulevard, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2006.12.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1905860PMC
April 2007

Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares.

J Rheumatol 2006 Sep 1;33(9):1878-80. Epub 2006 Jul 1.

Department of Medicine, State University of New York at Buffalo, New York, USA.

View Article

Download full-text PDF

Source
September 2006

Classification criteria for antiphospholipid syndrome: the case for cardiac valvular disease.

Authors:
Michelle A Petri

J Rheumatol 2004 Dec;31(12):2329-30

View Article

Download full-text PDF

Source
December 2004

Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.

J Rheumatol 2004 Dec;31(12):2390-4

Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
December 2004

Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.

Arthritis Rheum 2002 Jul;46(7):1820-9

Department of Medicine, John Hopkins Medical Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.10364DOI Listing
July 2002